Findings from Michael E. DeBakey VA Medical Center Update Knowledge of Opioids (Providers' Use of Pharmacogenetic Testing To Inform Opioid Prescribing Among Veterans).

A recent study conducted at the Michael E. DeBakey VA Medical Center in Houston, Texas, focused on the use of pharmacogenetic testing to inform opioid prescribing among veterans. The research found that only 10% of providers were aware of their patients' pharmacogenetic test results, with 55% believing that pharmacogenetic testing is valuable for guiding pain medication prescriptions. The study concluded that there are modifiable factors within the Veterans Health Administration that could be addressed to optimize pharmacogenetic testing for pain management. [Extracted from the article]